152 related articles for article (PubMed ID: 34953081)
21. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
22. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer.
Wu T; Li Y; Lu J; Qiao Q; Bao G; Wang N; He X; Du X
Med Oncol; 2013 Mar; 30(1):323. PubMed ID: 23275114
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
[TBL] [Abstract][Full Text] [Related]
24. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
25. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
Zhao XF; Yang YS; Park YK
Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.
Wang Y; Wang M
BMC Gastroenterol; 2016 Jul; 16(1):74. PubMed ID: 27457107
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
29. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
30. SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis.
Maimaiti Y; Maimaitiming M; Li Y; Aibibula S; Ainiwaer A; Aili A; Sun Z; Abudureyimu K
BMC Gastroenterol; 2018 Jan; 18(1):12. PubMed ID: 29338701
[TBL] [Abstract][Full Text] [Related]
31. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
34. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
35. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
Li L; Fu LQ; Wang HJ; Wang YY
Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
[TBL] [Abstract][Full Text] [Related]
36. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
37. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
38. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
Ying J; Xu Q; Zhang G; Liu B; Zhu L
Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
[TBL] [Abstract][Full Text] [Related]
40. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]